Recruiting Clinical Trials

Displaying 1 - 10 of 184 result(s)
Study Title Condition Phase Location
Assessing the Impact of Lipoprotein (a) Lowering With TQJ230 on Major Cardiovascular Events in Patients With CVD
  • Cardiovascular Disease and Lipoprotein(a)
  • Phase 3
  • Country: 
    United States
  • Country: 
    Argentina
  • Country: 
    Australia
  • Country: 
CINC424A2X01B Rollover Protocol
  • Primary Myelofibrosis
  • Chronic Idiopathic Myelofibrosis
  • Post Polycythemia Vera Myelofibrosis
  • Post Essential Thrombocythaemia Myelofibrosis
  • Steroid Refractory Graft Versus Host Disease
  • Phase 4
  • Country: 
    Australia
  • Country: 
    Belgium
  • Country: 
    Bulgaria
  • Country: 
Study to Evaluate the Efficacy and Safety of MAS825 in NLRC4-GOF Patients
  • NLRC4-GOF, AIFEC (Autoinflammation With Infantile Enterocolitis)
  • Phase 2
  • Country: 
    Japan
Activity, Safety and Pharmacokinetics in Pediatric Subjects With Moderate and Severe Chronic Graft vs. Host Disease After Allogeneic Stem Cell Transplant
  • Graft vs Host Disease
  • Phase 2
  • Country: 
    Brazil
  • Country: 
    Czechia
  • Country: 
    India
  • Country: 
A First-in-human Study to Investigate the Safety, Tolerability and Pharmacokinetics of MAS825 in Healthy Volunteers
  • Healthy Volunteers
  • Phase 1
  • Country: 
    United States
  • Country: 
    United Kingdom
Long Term Special Drug Use-results Surveillance for Mayzent in SPMS Patients
  • Secondary Progressive Multiple Sclerosis (SPMS)
  • Not Given
  • Country: 
    Japan
Efficacy and Safety of LNP023 Compared With Rituximab in Subjects With Idiopathic Membranous Nephropathy
  • Glomerulonephritis, Membranous
  • Phase 2
  • Country: 
    United States
  • Country: 
    Argentina
  • Country: 
    Czechia
  • Country: 
Study of Efficacy and Safety of LXH254 Combinations in Patients With Previously Treated Unresectable or Metastatic Melanoma
  • Melanoma
  • Phase 2
  • Country: 
    United States
  • Country: 
    Australia
  • Country: 
    Austria
  • Country: 
Digital Adherence Monitoring of Inhalative Therapy in Real- Life Conditions
  • Asthma
  • Not Given
  • Country: 
    Germany
Special Drug Use-results Surveillance of Tabrecta Tablets
  • Non-small Cell Lung Cancer
  • Not Given
  • Country: 
    Japan